None listed
Conditions
Interventions
None listed
Sponsors
Korea Institute of Oriental Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who visit participating Korean medicine hospitals with idiopathic facial nerve paralysis (G51.0) as the main symptom and have decided to receive Korean medicine treatment. 2) Patients within 4 weeks of the onset of facial nerve paralysis. 3) Patients who have received sufficient explanation prior to registry enrollment, voluntarily decided to participate in this study, and signed the IRB-approved written consent form.
Exclusion criteria
Exclusion criteria: 1) Patients who visit after 4 weeks from the onset. 2) Patients with facial nerve paralysis due to secondary causes (e.g., multiple sclerosis, tumors, cerebrovascular diseases, etc.). 3) Ramsay Hunt Syndrome patients. 4) Patients who cannot read or understand the consent form and questionnaire. 5) Patients deemed unsuitable for participation at the investigator's discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| House-Brackmann scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Sunnybrook Facial Grading Scale;Facial Nerve Grading System 2.0 (FNGS 2.0);Facial disability index (FDI);EQ-5D-5L, EQ-VAS;Patient Satisfaction Assessment;Blood test (AST, ALT, BUN, Cr);adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactSoo-Dam Kim
Korea Institute of Oriental Medicine
Outcome results
None listed